Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: David Israel-Rosen who wrote (732)	5/6/1998 12:33:00 PM
From: Merav	Read Replies (2) \| Respond to of 1491

Entremed-Pharmos story covered in last night's Globes, the Israeli financial daily. Unfortunately it's not in the Internet version. Includes an interview with Haim Aviv in which he says that the Pharmos and Entremed products are at similar stages of development. He notes the advantage of the Pharmos product over the Entremed product: the Entremed product is made from materials that are difficult to produce and not easily introduced into the body. The Pharmos product, in comparison, is easy to produce.